Stock market Updates | Wockhardt Ltd. | R Wadiwala Securities Pvt Ltd

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE1392.2544.05 (+3.27 %)
PREV CLOSE (Rs.) 1348.20
OPEN PRICE (Rs.) 1346.40
BID PRICE (QTY) 1389.95 (8)
OFFER PRICE (QTY) 1392.00 (2)
VOLUME 21507
TODAY'S LOW / HIGH (Rs.)1341.20 1404.70
52 WK LOW / HIGH (Rs.)1086.8 1870
NSE1390.4040.6 (+3.01 %)
PREV CLOSE( Rs. ) 1349.80
OPEN PRICE (Rs.) 1343.00
BID PRICE (QTY) 1390.40 (4)
OFFER PRICE (QTY) 1391.30 (43)
VOLUME 556093
TODAY'S LOW / HIGH(Rs.) 1336.60 1406.40
52 WK LOW / HIGH (Rs.)1086.7 1868.8

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
299.43
Dividend Yield(%)
0.00
TTM EPS (Rs.)
11.75
P/E Ratio
118.25
Book Value (Rs.)
179.35
Face Value (Rs.)
5
MCap (Rs. in Mn)
225864.11
Price/Earning (TTM)
60.39
Price/Sales (TTM)
14.31
Price/Book (MRQ)
7.75
PAT Margin (%)
-0.85
ROCE (%)
4.75
company info
Incorporation Year : 08-07 1999

Management Info :

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone : 0240-6632222 / 6694444

Website : www.wockhardt.com

Registrars Details :

MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
News
30Mar Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..
10Feb Wockhardt’s consolidated net profit
Wockhardt has reported results for third quarter ended December 31, 2025..
27Jan Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..
Financials
QTR Dec 25 ANNUAL 25
Net Profit280-120
Gross Profit 280 -120
Operating Profit 1400 3550
Net Sales 4300 14020
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Neuland Laboratories (BSE)
Rwadiwala-peer-arrow  14499.10 (3.19%)
M.Cap (Rs. in Cr)18618.73
Astrazeneca Pharma I (BSE)
Rwadiwala-peer-arrow  8026.25 (1.71%)
M.Cap (Rs. in Cr)20147.75
Sanofi Cons. Health (BSE)
Rwadiwala-peer-arrow  4600.00 (2.82%)
M.Cap (Rs. in Cr)10601.23
Alkem Laboratories (BSE)
Rwadiwala-peer-arrow  5372.15 (2.39%)
M.Cap (Rs. in Cr)64325.97
Shareholding Pattern
MUTUAL FUNDS/UTI
7.76%
PROMOTERS
49.08%
NON-INSTITUTION
33.36%
FI/BANKS/INSURANCE
0.31%
GOVERNMENT
0.02%
FII
0%